Candidates : Actualité Candidates en direct - P2 | Bourse Reflex
Accueil > Tags > Candidates

  • Toutes les actualités en rapport avec « Candidates »

21/09 17:40 Candidates - Genticel presents first half 2015 financial results, operational progress and outlook

28/07 18:00 Candidates - Business Update - Second Quarter 2015

19/06 18:00 Candidates - THEOLIA's General Meeting of Shareholders

17/04 12:00 Candidates - Trophée d'or pour Mersen

17/03 17:45 Candidates - Creation of a joint Inserm-Quantum Genomics laboratory at the Collège de France backed by the French National Agency for Research (ANR)

17/02 11:00 Candidates - Remarkable uptake in Quantum Genomics IPO* : EUR 11.2 million raised

27/01 19:20 Candidates - Business Update - Fourth Quarter 2014

19/10 16:35 Candidates - Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

14/10 08:30 Candidates - Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

06/10 16:05 Candidates - Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

03/10 20:05 Candidates - Apricus Biosciences Announces Korean Patent Approval for MycoVa(TM) for Nail Fungus

14/09 11:30 Candidates - Raptor Pharmaceutical Corp. Announces Closing of Public Offering of Common Stock

12/09 08:15 Candidates - Apricus Biosciences to Provide Overview of Rx and Consumer Healthcare Divisions at the 11th Annual Biotech in Europe Investor Forum

31/08 16:20 Candidates - Apricus Biosciences Receives FDA Clearance for Its Third OTC Drug Containing NexACT(R) Technology

24/08 14:00 Candidates - Cancer Prevention Pharmaceuticals Announces Completion of Bridge Financing Round

18/08 15:00 Candidates - Photo Release -- Apricus Biosciences Announces FDA Clearance for Its First Anti-Fungal OTC Drug (Tolnaftate-D(TM)) Containing NexACT(R) Technology

12/08 09:00 Candidates - Apricus Biosciences Announces Second Quarter 2011 Financial Results Conference Call

08/08 16:05 Candidates - Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America

05/08 09:00 Candidates - Apricus Biosciences Provides Corporate Mid-Year Update

29/07 09:00 Candidates - Cancer Prevention Pharmaceuticals Receives Positive Scientific Advice From EMA for CPP-1X Phase III TRIAL in FAP